Aug 09, 2018 4:00 pm EDT Capricor Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 02, 2018 4:00 pm EDT Capricor Therapeutics to Present Second Quarter Financial Results and Corporate Update on August 9
Jul 17, 2018 7:00 am EDT Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops
Jul 13, 2018 9:00 am EDT Capricor Therapeutics and PPMD to Host Webinar for Duchenne Muscular Dystrophy Community on July 18
May 29, 2018 7:00 am EDT Capricor Therapeutics to Present at the 2018 BIO International Convention in Boston
May 10, 2018 4:00 pm EDT Capricor Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 04, 2018 8:00 am EDT Capricor Therapeutics to Present First Quarter 2018 Financial Results and Corporate Update on May 10
May 03, 2018 7:00 am EDT Capricor to Present on Exosomes at the Plenary Session of the International Society for Cellular Therapy in Montreal
Apr 30, 2018 7:00 am EDT Capricor Announces Initiation of HOPE-2 Clinical Trial of CAP-1002 for Duchenne Muscular Dystrophy